2021
DOI: 10.1016/j.compbiolchem.2021.107482
|View full text |Cite
|
Sign up to set email alerts
|

The role of human C5a as a non-genomic target in corticosteroid therapy for management of severe COVID19

Abstract: Graphical abstract Illustrations of the C5a-prednisone complexes highlighting the range of estimated binding affinity.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
20
0

Year Published

2021
2021
2025
2025

Publication Types

Select...
9

Relationship

3
6

Authors

Journals

citations
Cited by 14 publications
(20 citation statements)
references
References 86 publications
0
20
0
Order By: Relevance
“…Corticosteroids act over diverse immune pathways but, overall, by inhibition of complement activation [178] and producing the apoptosis of T-lymphocytes and granulocytes [179]. In cases of RM/RPL, corticosteroids favor the establishment of early pregnancy by the suppression of dNK cells and improvement of trophoblast proliferation and invasion [180].…”
Section: Corticosteroidsmentioning
confidence: 99%
“…Corticosteroids act over diverse immune pathways but, overall, by inhibition of complement activation [178] and producing the apoptosis of T-lymphocytes and granulocytes [179]. In cases of RM/RPL, corticosteroids favor the establishment of early pregnancy by the suppression of dNK cells and improvement of trophoblast proliferation and invasion [180].…”
Section: Corticosteroidsmentioning
confidence: 99%
“…Furthermore, modulation of dendritic cell function, dysregulation of IFN-γ production, exhaustion of NK cell-mediated cytotoxicity [ 90 ] and antigenic variation [ 91 ] are some other ways to escape the innate immune defense. Likewise, hyperactivation of the complement cascade by SARS-CoV-2 triggers a vicious cycle of “hypercytokinaemia” [ 92 , 93 ] that aids in elevating levels of pro-inflammatory modulators, such as C3a and C5a [ 94–96 ] ( Figure 4 ) and increases the susceptibility to develop the severe acute respiratory distress syndrome [ 97 ]. Therefore, this modulation of the innate antiviral response induced by both host and viral factors gives a good head start to the viral replication in the URT and hyper-inflammation in the lungs, resulting in conditions that lead to COVID-19 severity.…”
Section: Host Virus Interaction (The Host Immune Response)mentioning
confidence: 99%
“…CD8+ lymphocytes destroy infected alveolar cells, while neutrophil and macrophage activation leads to the systematic inflammatory reaction syndrome (SIRs) and cytokine release syndrome [ 23 ]. Complement component C5a, acting as chemoattractant of neutrophils, potentiates the development of a deleterious hypercytokinaemia [ 24 ]. T-helper 17 polarization, occurring after neutrophil hyperactivation, seems to hold a central role in triggering a vicious cycle of inflammation and fibrosis [ 25 ].…”
Section: Covid-19 Clinical and Pathophysiological Aspectsmentioning
confidence: 99%
“…The endothelium is central to coagulation physiology, and its dysfunction explains at least partly the clinical complications (venous thromboembolic disease) and the laboratory hallmarks (elevated d-dimer, prothrombin time prolongation) of severe COVID-19 infection cases [ 12 , 32 ]. Of note, inflammation and coagulation share molecular pathways involving cytokines such as IL-8, IL-6, IL-1b [ 20 ] and complement components C3 and C5 [ 24 , 38 ]. Immune complexes containing antibodies against SARS-COV2 spike protein are also implicated in COVID-19 hypercoagulability through enhanced of FcγRIIA signaling [ 39 , 40 ].…”
Section: Covid-19 Clinical and Pathophysiological Aspectsmentioning
confidence: 99%